Wort "Medical Technology" umgeben von Symbolen - Reagenzglas, Arzt, Bluttest, Diagramm

Our medical technology portfolio – extensive expertise for sustainable and profitable growth.

Fundamental changes in healthcare such as new regulations, falling reimbursement rates and the growing number of purchasing associations are making it increasingly difficult for medical technology companies to remain on a path of growth and profitability in a conventional manner. At the same time, new topics such as value-based care, personalized medicine, digitization and the associated consumerization offer unprecedented opportunities.

In order to adequately meet these challenges, medical technology companies must understand the mechanisms of their market as well as individual customer requirements holistically. In a dynamic market environment, strategies, solutions and organizational structures must be consistently evaluated and aligned with the needs of patients, service providers and payers. Previously untapped potentials in market development must be identified in order to act more successfully.

Homburg & Partner supports medical technology and diagnostic consumer and capital goods suppliers on a global level with dedicated teams specialized in the industry. We advise listed and medium-sized companies as well as start-ups. We have many years of experience and excellent expertise in medical technology, especially in the following key areas:

Gene Therapies whitepaper: Title view
Whitepaper | 35 pages | Free download

Gene therapies offer great curative potential – but their go-to-market has many obstacles. How can pharmaceutical companies succeed?

Our services for medical technology companies:

Leuchtende gelbe Glühbirne, gezeichnet
New Product Development

Successful innovations by means of comprehensive market analysis.

Learn more
Schema aus mehreren Boxen, die von Unordnung zu Ordnung übergehen
Commercial Innovation

Grow with the power of innovation in the market for medical technology.

Learn more
Drei Schachfiguren - König und zwei Türme
Market Strategy Excellence

Lay the foundation for successful strategic growth of your company.

Startende gezeichnete Rakete
Digital Transformation

The digital future is now – our approach to transforming your business.

Learn more
Drei Personen mit Herzen und einem Wachstumspfeil oberhalb
Commercial Model

Insight into the customer’s situation as a guarantee for lasting competitiveness.

Learn more
Lupe, die auf einen Server zeigt
Segmentierung & Targeting

Achieve your business goals with an efficient and well-trained sales force.

Laptop, auf dessen Bildschirm eine Wachstumskurve sichtbar ist
Sales Excellence

Our proven Sales Excellence approach for your sales success and sustainable growth.

Learn more
Abakus mit zwei Dollar-Zeichen oberhalb
Price Stabilization

Effectively countering the drop in prices with our proven STOP approach.

Learn more
Laptop, auf dessen Bildschirm eine Wachstumskurve sichtbar ist mit einem Geldschein oberhalb
Pricing Excellence

Professional pricing as the core element of your company’s success.

In the medical technology sector, Homburg & Partner distinguishes between the following three segments:

Homburg & Partner has been advising providers of in-vitro (e.g. high-throughput equipment, point-of-care testing or patient self-testing) and in-vivo diagnostics (e.g. CRT, MRI or X-ray equipment) solutions for diagnosing the state of health of patients for more than ten years.

Whether endoscopes, surgical devices or respiration technologies – nationally and internationally active manufacturers of medical devices profit from their cooperation with Homburg & Partner through exclusive market insights.

Manufacturers of components with lower technical characteristics such as consumables for outpatient and hospital care have trusted Homburg & Partner for decades.

Our experts for medical technology

Porträtbild von Michael Scholl
Managing Director & Partner

Dr. Michael Scholl

michael.scholl@homburg-partner.com
Tel.: +49 621 1582-0

Porträtbild unseres Partners Karl-Hubertus Gruber
Partner

Karl-Hubertus Gruber

karl-hubertus.gruber@homburg-partner.com
Tel.: +49 211 598929-59

Porträtbild von Michael Marquardt
Principal

Dr. Michael Marquardt

michael.marquardt@homburg-partner.com
Tel.: +49 621 1582-148

Medical Technology |  Current topics

Rissige Gesteinsplatten mit Spalten, aus denen orange Lava hervorschimmert

Breaking through the sales plateau in 3 stages

In the US most medium-sized in-vitro-diagnostic (IVD) companies are confronted with a growth hurdle when the sales of their introductory products begin to plateau. This may be a result of changing customer needs, first competitors’ reactions or simply of products having reached their natural revenue peak in the US. To overcome this critical hurdle, companies have to quickly adapt their strategy to the new situation in terms of a market growth perspective. In numerous growth projects, we developed a how-to for midsize IVD companies in order to overcome their most critical growth hurdle.
Boosting Clinical Sales Thumb

Boosting That Bottom Line: Three Portfolio Pricing Tricks

Increasing the price of your product constitutes one of the most direct ways to enhance profits, turning them into an effective means to improve the bottom line in the short term: Profit gains resulting from price increases are not only exempt from any additional costs, but they become almost immediately visible in a company’s financial reports. In this article, Karl-Hubertus Gruber and Michael Marquardt from Homburg & Partner reveal three techniques medtech companies can use to hike their profits.

Quo Vadis In Vitro Diagnostics?

The in vitro diagnostics industry is expected to undergo a transformation. Learn more about the potential disruptors and what IVD companies can do to keep pace.

Would you like to learn more? Nothing easier than that!

If you’d like to make a project enquiry or find out more about our services, you can use the form to send a contact request. It just takes a few seconds! One of our industry experts will get in touch with you soon.